Skip to main content
Published locations for Low-risk MDS: Oral azacitidine provides meaningful reduction in RBC transfusion burden
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Low-risk MDS: Oral azacitidine provides meaningful reduction in RBC transfusion burden
User login
Username
Password
Reset your password
/content/low-risk-mds-oral-azacitidine-provides-meaningful-reduction-rbc-transfusion-burden
/hematology-oncology/article/238070/myelodysplastic-syndrome/low-risk-mds-oral-azacitidine-provides